Clinical Trials Browser

Lymphoma × Radiotherapy, Intensity-Modulated × 1 year × Clear all

NCT05371132 2026-01-28

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Phase 1 Recruiting

Lymphoma, Neoplasm Metastasis